|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2007-7-31
|
|
pubmed:abstractText |
Single-agent chemotherapy is usually effective in HIV-associated multicentric Castleman's disease (MCD). However, in most patients, chemotherapy cannot be discontinued.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AgbalikaFelixF,
pubmed-author:BéreznéAliceA,
pubmed-author:BoulangerEmmanuelleE,
pubmed-author:ChevretSylvieS,
pubmed-author:De CastroNathalieN,
pubmed-author:GérardLaurenceL,
pubmed-author:GalicierLionelL,
pubmed-author:JacometChristineC,
pubmed-author:Madelaine-ChambrinIsabelleI,
pubmed-author:MeigninVéroniqueV,
pubmed-author:ObadiaMartineM,
pubmed-author:OksenhendlerEricE,
pubmed-author:VerdonRenaudR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3350-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17664482-Adult,
pubmed-meshheading:17664482-Aged,
pubmed-meshheading:17664482-Antibodies, Monoclonal,
pubmed-meshheading:17664482-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17664482-Female,
pubmed-meshheading:17664482-Giant Lymph Node Hyperplasia,
pubmed-meshheading:17664482-HIV Infections,
pubmed-meshheading:17664482-Humans,
pubmed-meshheading:17664482-Infusions, Intravenous,
pubmed-meshheading:17664482-Male,
pubmed-meshheading:17664482-Middle Aged,
pubmed-meshheading:17664482-Polymerase Chain Reaction,
pubmed-meshheading:17664482-Prospective Studies,
pubmed-meshheading:17664482-Survival Analysis,
pubmed-meshheading:17664482-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
|
|
pubmed:affiliation |
Department of Clinical Immunology, Laboratory of Virology, Paris VII University, Paris, France. laurence.gerard@sls.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
